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A B S T R A C T
Objective: Screening for cervical cancer may have favourable or unfavourable effects at the individual
level. This study assesses whether invitees in the Netherlands made an informed choice about screen
uptake.
Methods: Attached to the invitation letter and the information leaﬂet, screen invitees were sent a
questionnaire. An informed decision was deﬁned as based on decision-relevant knowledge, while the
woman’s attitude was consistent with her actual screening behaviour.
Results: Of all cervical screen participants, 60% (924/1551) responded to the questionnaire. Decision-
relevant knowledge was sufﬁcient in 595 women. Especially knowledge about false-positive and false-
negative test results was limited. The attitude towards cervical screening was mainly positive (99%).
Requirements for informed decision making were met in 571 (68%) women and in 91% when an
alternative cut-off point of sufﬁcient decision-relevant knowledge was applied. Most frequently
reported main reasons to attend were early detection of abnormalities (67%) and reassurance in case of a
normal smear (22%).
Conclusion: Insufﬁcient decision-relevant knowledge was the main cause of uninformed attendance.
Practice implication: Adequate strategies to provide invitees with sufﬁcient decision-relevant informa-
tion are still needed, especially regarding false-positive and false-negative test results.
 2011 Elsevier Ireland Ltd. 
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Traditionally, population-based cancer screening programs
aimed at maximizing uptake and thus effectiveness at the
population level. However, at the individual level, screening
attendance involves careful consideration between uncertain
beneﬁts, e.g. a longer duration of life in case (a precursor of)
cancer is successfully detected and treated, and the risks of adverse
effects, e.g. unnecessary treatment of inconsequential neoplasia, or
early diagnosis and longer morbidity for people whose prognosis
remains bad [1,2]. The mortality reduction in cervical cancer as a
result of population-based screening in the Netherlands is
estimated to be 50–75% [3]. With a mortality rate of 214 in
2006 [4], this translates to a mortality reduction of about 300 cases
as an effect of screening. On the other hand, of all 507,676 women* Corresponding author at: Erasmus MC, Dept. of Public Health, P.O. Box 2040,
3000 CA Rotterdam, The Netherlands. Tel.: +31 10 703 8460; fax: +31 10 703 8475.
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Open access under the Elsevier OA license.that participated in screening in 2006 2895 (0.6%) had high-grade
abnormal smears. In another 10,328 (2%) participating women
low-grade abnormalities were found, i.e. borderline (Pap 2) or
mildly (Pap 3a1) dyskaryotic (BMD) Pap smear results. These
women were advised to have repeat smears within 6 months. In
about 30% of them BMD then persisted, or the abnormality
increased in severity, and they were referred for a colposcopy [5].
Thus the number of women that are being saved from a cervical
cancer death thanks to screening (about 300/500,000; 0.06%) is
much lower than the number of women advised to have repeat
smears because of low grade abnormal results and the number of
women treated for high grade abnormalities that are not
necessarily cancer. This shows that in cervical cancer screening,
the individual chance of beneﬁt in the sense of a better patient
outcome (e.g. longer life expectancy) is much lower than the risk of
adverse effects such as unnecessary treatment of inconsequential
neoplasia.
By providing information that emphasizes the favourable
aspects of screening, the autonomy of individuals is ignored [6].
In several Western countries, a shift in policy has occurred [7] and
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prenatal and cancer screening) has become an explicit purpose
[8,9]. In this view, people are entitled to make their individual
deliberation about the pros and cons of screening programs and
make an autonomous choice about uptake [10]. Following Marteau
et al., we deﬁned an informed choice as one that is based on
relevant knowledge while the decision-maker’s attitude was
consistent with her actual screen behaviour [11]. Note that in
applying the concept of informed choice, non-attendance of a
screening program can be a perfectly acceptable outcome of the
deliberative process if it is based on sufﬁcient decision-relevant
knowledge and consistent with the decision-maker’s attitude
towards participating in the screening program [11].
In the Netherlands, as in many other countries, cervical cancer
screening is organised as a population-based program. Since 1996,
screening is offered free of charge to all women aged 30–60 years.
The screening interval is 5 years. Nationally, the uptake rate of
cervical cancer screening is 65% [12]. When the present study was
conducted, neither HPV screening nor HPV vaccination had been
introduced.
The present study examines to what extent uptake of cervical
cancer screening is based on an informed decision because, until
now, this aspect of screening has not been measured.
2. Methods
2.1. Study design
Between April and August 2006 a longitudinal cohort study was
conducted among participants of the National Cervical Cancer
Screening Program in the region of Limburg, the Netherlands. A
randomly selected group of women (aged 30–60 years) was
approached, i.e. women who were due to be invited in the
particular weeks we were conducting our study, stratiﬁed in 7 ﬁve-
year age groups. A questionnaire (described in detail below) was
attached to their screen invitation together with the standard
information leaﬂet about the screening program. In an accompa-
nying letter, women were asked to complete the questionnaire;
they were assured that not completing it would not have any
consequences for their medical care. If the questionnaire was not
returned within one month, a reminder was sent.
The data reported here are of women who (1) returned the
questionnaire, and (2) participated in cervical cancer screening; all
these women are referred to as ‘participants’. To assess a possible
non-response bias, the average age of participants is compared to
that of women who had a Pap smear but did not respond to the
questionnaire.
This study was part of a comprehensive evaluation of the Dutch
cervical cancer-screening program. The ethics review committees
of the Erasmus MC, University Medical Center Rotterdam, and of
the University Hospital Maastricht approved the research protocol.
2.2. Content of the questionnaire
To assess the level of decision-relevant knowledge, we included
5 multiple-choice items related to aspects of screening that are
considered relevant by Wald [13]: these include the medical
disorder being screened for, the screening test, and the subsequent
steps following a screening test (Table 2 lists the items). False-
positive and false-negative test results were addressed through
two statements with response options ‘true, not true, don’t know’.
Currently, sufﬁcient knowledge is indicated using distribution-
based methods (e.g. below or above the mean score) [11] or, as we
recommend, using anchor-based methods (e.g. a certain percent-
age of correctly answered items) [14]. Since the deﬁnition of
sufﬁcient decision-relevant knowledge is to some extent arbitrary,we operationalized a ‘‘sufﬁcient level of decision-relevant knowl-
edge’’ in two different ways: (A) as at least 6 out of 7 correctly
answered items, thus leaving all other outcomes as ‘‘insufﬁcient
decision-relevant knowledge’’, or (B) as at least 5 out of 7 correctly
answered items.
The participants’ attitude towards cervical cancer screening
was measured through an attitude scale that was adapted from the
multidimensional measure for informed choice of Marteau et al.
[11], addressing how women perceived their uptake of prenatal
screening. It consists of 6 cognitive items, e.g. did women consider
their participation in cervical cancer screening important vs.
unimportant, and of 3 affective items, e.g. did women consider
their participation in cervical cancer screening as reassuring vs.
frightening. Response options were on a 5-point Likert scale,
ranging from ‘important’ to ‘unimportant’, ‘reassuring’ to ‘fright-
ening’, etc.
The questionnaire also included items on participants’ main
reasons to attend screening, on anticipated regret and/or worry
(i.e. the regret and/or worry anticipated by a woman in case she
decided not to participate in screening and cancer was clinically
diagnosed later on, response options were 5-point Likert scales,
ranging from ‘no, certainly not’ to ‘yes, certainly’), and on women’s
opinion about the extent of information provided by the screen
organisation (too limited/sufﬁcient/too extended).
2.3. Participants’ characteristics
Information on participants’ marital status, education, employ-
ment status, and own as well as parents’ country of birth was
obtained through the initial questionnaire. Educational level was
classiﬁed as low (primary school or lower technical education),
intermediate or high (college/university degree).
Data on screen uptake at the individual level were provided by
the screen organisation after permission had been granted by the
women involved (not all women gave permission).
2.4. Informed or uninformed choice
Currently, there is no generally accepted standard measure of
informed choice in cancer screening. Therefore, we applied the
concept of informed choice as developed by Marteau et al. for
prenatal screening [11], which is based on the theory of planned
behaviour [15]. Marteau et al. deﬁned an informed choice as one
that is based on relevant knowledge while the decision maker’s
attitude was consistent with her actual screen behaviour [11]. This
implies that an informed choice to undergo a cervical cancer
screening test occurs when a woman (1) has sufﬁcient relevant
knowledge about the test, (2) has a positive attitude towards
undergoing the test, and (3) does undergo the test. If a woman has
(1) relevant knowledge about the test, (2) a negative attitude, and
(3) does not undergo the test, she also makes an informed choice.
All other combinations are considered uninformed choices.
Participants’ knowledge about and attitude towards the
cervical screening program were examined via the questionnaire.
The screening organisation provided data on screen uptake at the
group level. Individual data were provided after the women
involved had granted permission (not all women gave permission).
Women whose uptake was unknown at the individual level were
excluded from the study.
2.5. Statistical analyses
In accordance with guidelines [16], missing items in the scale
on attitude towards cervical cancer screening were imputed by
participants’ own average score if at least 50% of these items had
been completed. To facilitate interpretation, the results were
Table 1
Background characteristics of the responding screen participants.
Screen participants n = 905
Age (years)
Average (SD) 45.3 (9.4)
Median 45.0
Range 29–60
Educationa (%)
Low 181 (22)
Medium 410 (50)
High 227 (28)
Employment status (%)
Paid job 541 (68)
Housewife/unpaid/job/student 178 (22)
No job 64 (8)
Retired 14 (2)
Marital status (%)
Married/cohabiting 715 (79)
Living without partner 185 (21)
Children (%)
Yes 663 (79)
Average no. 2
Country of birth (%)
The Netherlands 806 (99)
Country of birth of parents (%)
Father born in the Netherlands 792 (99)
Mother born in the Netherlands 786 (99)
a Educational level was classiﬁed as low (primary school or lower technical
education), and intermediate/high (college/university degree).
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[17], because we consider that mid-point scale responses reﬂect
neither a positive nor a negative attitude, we classiﬁed scores in the
range 45–55 as a ‘neutral attitude’. Scores below 45 were classiﬁed
as a ‘negative attitude’, scores above 55 as a ‘positive attitude’.
Using the concept of sufﬁcient statistics, a p-value for the
differences in participants’ age was constructed between screen
participants who responded to the questionnaire and those who
did not, based on the numbers of observations, the means and theTable 2
Knowledge about the screen program among screen participants (n = 905).
Knowledge items Response possibilit
Multiple choice items
Why did the screening organisation invite you to
have a Pap smear?
- To early detect c
- To treat cervical c
- I don’t know
- For another reaso
Why are women in the ages 30-60 years invited
for cervical screening?
- Cervical cancer is
- This is the childbe
- Cure is possible in
- It is easy to detec
What does a Pap smear involve? - The doctor assess
- The doctor assess
- A sample of cells
- The doctor assess
What happens in case of a normal test result? - Nothing will hap
- I’ll receive an inv
- I’ll have an additi
- I’ll have to registe
What happens in case of an abnormal test result? - Nothing will happ
- I’ll have to have 
- I’ll be referred to
- I’ll get medication
True/not true statements
Possibility of false-positive
If my Pap smear is abnormal, I deﬁnitely have
cervical cancer
- True
- Not true
- I don’t know
Possibility of false-negative
If my Pap smear is normal I deﬁnitely don’t have
cervical cancer
- True
- Not true
- I don’t know
a Correct answers are indicated in bold.
b This applies to 60-year-olds; the option beneath it applies to all other participantsstandard deviations [18]. Statistical analyses were performed
using SPSS for Windows, version 15. A p-value 0.05 (two-sided
statistical tests) was considered statistically signiﬁcant.
3. Results
3.1. Characteristics of screen participants
The questionnaire was completed by 60% (924/1551) of the
approached screen participants. Participation was known at the
individual level in 905 cases. The majority of participants had a
paid job, were married or cohabiting, had children, and were born
in the Netherlands (Table 1). Non-responding screen participants
were slightly younger than respondents, i.e. 44.9 vs. 45.3 years,
respectively (p = 0.41).
3.2. Knowledge, attitude and informed decision making
Most knowledge items on cervical screening were answered
correctly (91–99% correct answers per question), whereas answers
regarding test characteristics were less often correct. Of the screen
participants, 74% were aware that Pap smear results could be false
positive and 42% knew about the existence of false-negative Pap
smear results (Table 2). Overall, the attitude towards cervical
screening was mainly positive (Table 3). The Cronbach alpha of the
attitude scale (indicating its internal consistency) was 0.67.
Applying an operationalization of sufﬁcient knowledge as at
least 6 out of 7 correctly answered items, the requirements of
informed decision making were met in 571 (68%) screen
participants (Table 4). All these women had sufﬁcient knowledge,
a positive attitude and had undergone a smear test. Because almost
all women had a positive attitude, uninformed decision making
was mainly due to insufﬁcient decision-relevant knowledge; 261
women with a positive attitude had a smear taken but, because of
their low knowledge scores, these decisions were not considered to
be ‘informed’. When the second operationalization of sufﬁcientiesa No. (%) with correct answers
ervical cancer
ancer
n
849 (99%)
 most prevalent in this age group
aring age
 this age group
t in this age group
791 (91%)
es the urine composition
es blood sediment
 is taken from the cervix
es the intersection of the cervix
860 (99%)
penb
itation in 5 years time
onal investigation
r for the next smear
842 (97%)
en
a repeat Pap smear
 the hospital to have further tests
839 (96%)
635 (74%)
361 (42%)
.
Table 3
Knowledge about and attitude towards cervical cancer screening, and reasons to
have a smear (%).
Screen participants n = 905
Decision-relevant knowledge about cervical cancer screening
(A) Sufﬁcient level (at least 6 out of 7
correctly answered items)
595 (67)
(B) Sufﬁcient level (at least 5 out of 7
correctly answered items)
810 (91)
Attitude towards cervical cancer screening
Positive 833 (99)
Neutral 9 (1)
Negative 4 (1)
Women’s main reasons to have a Pap smear
Early detection 428 (67)
Reassurance 144 (22)
I don’t have a reason to have a Pap smear 18 (3)
Anticipated regret
No, certainly/probably not 36 (4)
Neutral 58 (7)
Yes, probably/certainly 763 (89)
Anticipated worry
No, certainly/probably not 140 (16)
Neutral 144 (17)
Yes, probably/certainly 568 (67)
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proportion of decisions meeting the requirements of informed
choice increased to 91%.
3.3. Reasons to participate and information about the screening
program
The most frequently reported main reasons to participate in
cervical screening were early detection of abnormalities (67%), and
reassurance in the case of a normal Pap smear (22%) (Table 3). Most
women anticipated regret (89%) and/or worry (67%) if they would
decide not to have a smear taken.
Of all participants, 95% considered the amount of information
received from the screening organisation to be sufﬁcient, 2% thought
it was too limited and 3% thought it was too extensive. When
deciding whether or not to have a Pap smear taken, 33% of the
participants consulted the information leaﬂet provided by the
screening organisation, 8% asked family or friends, and 1% consulted
the website of the screening organisation (data not in tables).Table 4
Informed choice among screen participants using two levels of sufﬁcient decision-
relevant knowledge.
Screen participantsa n = 845
(A) Sufﬁcient level: at least 6 out of 7 correctly answered items
Sufﬁcient level of decision-relevant knowledge
Positive attitude 571b (68%)
Neutral attitude 5 (1%)
Negative attitude 2 (0%)
Insufﬁcient level of decision-relevant knowledge
Positive attitude 261 (31%)
Neutral attitude 4 (0%)
Negative attitude 2 (0%)
(B) Sufﬁcient level: at least 5 out of 7 correctly answered items
Sufﬁcient level of decision-relevant knowledge
Positive attitude 773b (91%)
Neutral attitude 7 (1%)
Negative attitude 4 (0%)
Insufﬁcient level of decision-relevant knowledge
Positive attitude 59 (6%)
Neutral attitude 2 (0%)
Negative attitude 0
a Due to missing data the total number of women in this table is less than 905.
b The criteria of informed decision making were met in these groups.4. Discussion and conclusion
4.1. Discussion
The present study shows that decision making about screen
uptake met the requirements for informed choice in about 70% of
the screen participants, and in 91% when an alternative cut-off
point of sufﬁcient decision-relevant knowledge was applied.
To our knowledge, there are no published reports on the extent
of informed uptake of cervical cancer screening. In the present
study, the mainly positive attitude found towards cervical
screening is probably because the study population consists of
screen participants. Attitudes towards the screening program may
be less positive among women not participating in screening.
However, even women not participating may have intended to do
so, but may have declined participation due to external barriers or
to, for example, illness or forgetfulness [3]. This needs further
study.
While 95% of the women considered the amount of information
received from the screening organisation to be sufﬁcient, this was
not reﬂected in a rate of 95% correctly answered knowledge items.
Insufﬁcient decision-relevant knowledge could be due to low
levels of information-seeking behaviour among screen partici-
pants; in turn, this might be because women consider uptake of
cervical cancer screening a routine matter and not something that
needs extensive deliberation. However, we agree with Irwig et al.
that, even though not all screen invitees will want to make an
individually based choice, all invitees ‘should be aware of the
screening programme and have received and understood an agreed
minimum of information about beneﬁts and harms of the procedure’
[19]. Such an agreed minimum of information (also referred to as
‘core disclosure’) can enable screen invitees to ask relevant
questions and also help them decide whether (or not) they want
to take the recommended action.
The only knowledge domain that appeared to be poorly
understood by a large proportion of participants was the
possibility of false-positive or false-negative smear results. Similar
results were found in a colorectal cancer screening trial, where 47%
of a sample of 9594 invitees thought that a negative FOBT result
excluded the presence of colorectal cancer [20]. Misconceptions
about test characteristics may, e.g. result in increased anxiety
because of borderline or mild dyskaryotic smear test results [21].
Misconceptions may also result in an undesirable patient delay
after negative tests. If a woman believes that screening gives full
protection and thinks that ‘everything is ﬁne’ because her smear
results were normal, she may disregard later cancer alarm
symptoms [6]. A questionnaire study in the UK showed that the
proportion of women that correctly understood the meaning of a
normal smear result increased from 50% to 70% if an additional
sentence about a residual risk of having or developing cervical
cancer over the next ﬁve years was added [22]. We recommend the
addition of such a sentence to the information leaﬂet about the
cervical cancer screening program.
Since most of the participants had a positive attitude towards
the screening program, uninformed decision making was mainly
caused by insufﬁcient knowledge. This implies that the deﬁnition
of what exactly constitutes ‘sufﬁcient decision-relevant knowl-
edge’ had an important impact on the resulting proportion of
informed choice. The decision about what information is consid-
ered necessary to make an informed choice is arbitrary. As stated
by Green et al., the question is ‘‘What is it they need to know and
whose business is it to decide that?’’ [23]. Another question is related
to how much knowledge someone needs to have to qualify for
informed decision making. The two levels of informed decision
making that we found (67% and 91%) show that the operationa-
lization of sufﬁcient knowledge is an important determinant of the
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is indicated using distribution-based methods (e.g. below or above
the mean score) [11] or, as we recommend, anchor-based methods
(e.g. a certain percentage of correctly answered items) [14]. We
conclude that there is a need to deﬁne (based on consensus) the
content and levels of knowledge needed to make an informed
decision about cancer screening participation.
The present study has some limitations. The response rate to
the questionnaire was 60%. Also, the questionnaire may have
induced more careful reading of the information leaﬂet provided
by the screening organisation, resulting in artiﬁcially high
knowledge scores. Although we assessed if screen participants
were aware of the possibility of a false-positive or false-negative
test result, we did not assess if women were aware of the current
rates of such false test results in the Netherlands. Thus we cannot
conﬁrm whether women’s decisions about uptake were related to
their opinions about the program’s test characteristics, nor do we
know how changes to these characteristics might affect screen
uptake.
The strengths of this study include the large number of
participants, the context of an implemented screening program
with study participants facing real uptake decisions, and the
availability of data on the actual implemented action. Although
women who decline screening have been relatively well investi-
gated, few data are available on women who do participate.
4.2. Conclusion
The results show that screen uptake was based on an informed
decision in 68% of participants and in 91% when an alternative cut-
off point of sufﬁcient decision-relevant knowledge was applied.
Insufﬁcient knowledge, mainly related to the possibility of false-
positive or false-negative Pap-smear results, was the main cause of
uninformed screen uptake.
4.3. Practice implications
Even in well-established cancer screening programs, adequate
strategies to provide invitees with sufﬁcient decision-relevant
information are still required and may need improvement,
especially regarding the possibility of false-positive and false-
negative screen outcomes.
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